TS3621691746	drug 93 102	bosutinib
TS1321691746	drug 143 152	Bosutinib
TS3421691746	drug 174 208	Src  Abl tyrosine kinase inhibitor
TS3521691746	treatedDisease 273 301	chronic myelogenous leukemia
TS2221691746	drug 468 477	bosutinib
TS1121691746	drug 613 622	bosutinib
TS421691746	drug 652 661	bosutinib
TS921691746	food 696 700	food
TS1021691746	food 726 730	food
TS621691746	drug 1023 1032	bosutinib
TS1921691746	sideeffect 1055 1063	diarrhea
TS2021691746	sideeffect 1074 1080	nausea
TS3021691746	sideeffect 1095 1103	headache
TS2321691746	drug 1114 1123	Bosutinib
TS3221691746	food 1140 1144	food
TS821691746	drug 1175 1184	Bosutinib
TS521691746	food 1275 1279	food
TS121691746	food 1557 1561	food
TS2421691746	drug 1604 1613	bosutinib
TS2521691746	drug 1729 1738	bosutinib
TS221691746	food 1761 1765	food
TS2921691746	mealTime 1801 1808	fasting
TS2621691746	drug 1847 1856	bosutinib
TS321691746	food 1862 1866	food
R2	relation Arg1:TS221691746 Arg2:TS2621691746
TS2821691746	drug 1979 1988	Bosutinib
TS3121691746	food 2005 2009	food
TS2721691746	mealTime 2046 2049	fed
TS1221691746	drug 2063 2072	bosutinib
R5	relation Arg1:TS2721691746 Arg2:TS1221691746
T1	drug 105 112	SKI-606
T2	drug 155 162	SKI-606
R6	treat Arg1:TS3421691746 Arg2:TS3521691746	
R7	treat Arg1:TS1321691746 Arg2:TS3521691746	
T3	treatedDisease 304 307	CML
T4	modeadm 608 612	oral
T5	dosage 662 690	200 , 400 , 600 , and 800 mg
T6	dosage 703 717	200 and 400 mg
T7	sideeffect 984 1006	adverse events ( AEs )
T8	sideeffect 1042 1045	AEs
T9	dosage 1124 1134	200-600 mg
T10	dosage 1256 1269	200 to 800 mg
R1	relation Arg1:TS121691746 Arg2:TS2421691746	
T11	dosage 1722 1728	200 mg
T12	dosage 1840 1846	400 mg
R3	increase_absorption Arg1:TS321691746 Arg2:TS2621691746	
T13	dosage 1989 1999	200-600 mg
T14	frequency 2195 2205	once-daily
